Baidu
map

贝克曼库尔特与Quidel产生商业纠纷 欲直接出售脑钠肽检测系统

2017-11-29 佚名 MedSci原创

加州布雷亚2017年11月28日电 /美通社/ -- 美国贝克曼库尔特有限公司(Beckman Coulter)一直致力于确保客户按时得到最优质的检测系统,以帮助医疗保健和实验室专业人士提供更好的患者护理。为了推进这些目标,该公司打算未来直接向客户出售用于Access免疫分析系统系列的利钠肽检测产品。目前,贝克曼库尔特为客户提供由该公司研发和生产,但通过Quidel及其指定经销商独家销售的脑钠肽(BNP)检测系统。Quidel不久前与美艾利尔(Alere)达成了一项交易,因而接管了这一销售工作。今天,贝克曼库尔特向加州的圣迭戈法院提出请求,要求澄清并强制执行该公司向客户直接出售利钠肽检测系统的权利。在解决这项法律问题期间,贝克曼库尔特制造和向Quidel供应TRIAGE®脑钠肽检测系统,以及Quidel的客户关系不受影响,客户可以放心,用在贝克曼库尔特分析仪上的优质脑钠肽检测系统将保持不间断供应。

贝克曼库尔特有限公司简介

贝克曼库尔特临床诊断业务部(Beckman Coulter Diagnostics)帮助医疗保健和实验室专业人士提供更好的患者护理,随时为他们带来所需的精确的诊断信息。80多年来,贝克曼库尔特一直是医疗保健组织的首选合作伙伴。他们可扩展的仪器设备、全面的诊断测试和业务管理服务备受全球医院、实验室和其他重症监护机构的信赖。该公司与客户肩负同样的使命,不断改进并打造优质的患者护理。该公司相信,只要效率和临床结果得到改善,患者就会受益,而公司也能为所有人提供更好的医疗保健服务。

© 2017 贝克曼库尔特有限公司,文中出现的固定标识和贝克曼库尔特产品及服务标记是贝克曼库尔特有限公司在美国及其他国家的商标或注册商标。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1654239, encodeId=d7e1165423992, content=<a href='/topic/show?id=9ee8851666c' target=_blank style='color:#2F92EE;'>#脑钠肽#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85166, encryptionId=9ee8851666c, topicName=脑钠肽)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad2e24479777, createdName=by2017, createdTime=Fri Mar 09 05:12:00 CST 2018, time=2018-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771768, encodeId=c9381e71768a9, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40059, encryptionId=62754005931, topicName=商业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd6238344589, createdName=zhangxingru, createdTime=Thu Mar 01 00:12:00 CST 2018, time=2018-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536401, encodeId=fd2c15364015f, content=<a href='/topic/show?id=c054e70973c' target=_blank style='color:#2F92EE;'>#纠纷#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77097, encryptionId=c054e70973c, topicName=纠纷)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74d012693594, createdName=ewsr5, createdTime=Fri Dec 01 00:12:00 CST 2017, time=2017-12-01, status=1, ipAttribution=)]
    2018-03-09 by2017
  2. [GetPortalCommentsPageByObjectIdResponse(id=1654239, encodeId=d7e1165423992, content=<a href='/topic/show?id=9ee8851666c' target=_blank style='color:#2F92EE;'>#脑钠肽#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85166, encryptionId=9ee8851666c, topicName=脑钠肽)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad2e24479777, createdName=by2017, createdTime=Fri Mar 09 05:12:00 CST 2018, time=2018-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771768, encodeId=c9381e71768a9, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40059, encryptionId=62754005931, topicName=商业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd6238344589, createdName=zhangxingru, createdTime=Thu Mar 01 00:12:00 CST 2018, time=2018-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536401, encodeId=fd2c15364015f, content=<a href='/topic/show?id=c054e70973c' target=_blank style='color:#2F92EE;'>#纠纷#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77097, encryptionId=c054e70973c, topicName=纠纷)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74d012693594, createdName=ewsr5, createdTime=Fri Dec 01 00:12:00 CST 2017, time=2017-12-01, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1654239, encodeId=d7e1165423992, content=<a href='/topic/show?id=9ee8851666c' target=_blank style='color:#2F92EE;'>#脑钠肽#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85166, encryptionId=9ee8851666c, topicName=脑钠肽)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad2e24479777, createdName=by2017, createdTime=Fri Mar 09 05:12:00 CST 2018, time=2018-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771768, encodeId=c9381e71768a9, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40059, encryptionId=62754005931, topicName=商业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd6238344589, createdName=zhangxingru, createdTime=Thu Mar 01 00:12:00 CST 2018, time=2018-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536401, encodeId=fd2c15364015f, content=<a href='/topic/show?id=c054e70973c' target=_blank style='color:#2F92EE;'>#纠纷#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77097, encryptionId=c054e70973c, topicName=纠纷)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74d012693594, createdName=ewsr5, createdTime=Fri Dec 01 00:12:00 CST 2017, time=2017-12-01, status=1, ipAttribution=)]
    2017-12-01 ewsr5

相关资讯

让爱有声 人工耳蜗风雨里程20年暨第17届宝迪康植入者日活动

/* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a.prnews_a { color:blue; } li.prnews_

赛诺菲与阿里健康携手推出“指尖上的安心”用药安全与疾病管理项目

/* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a.prnews_a { color:blue; } li.prnews_

Baidu
map
Baidu
map
Baidu
map